These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20218794)

  • 1. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Romeo E; Rupprecht R
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.
    Schüle C; Romeo E; Uzunov DP; Eser D; di Michele F; Baghai TC; Pasini A; Schwarz M; Kempter H; Rupprecht R
    Mol Psychiatry; 2006 Mar; 11(3):261-72. PubMed ID: 16344854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
    Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
    J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combination treatment with mood stabilizers and mirtazapine on plasma concentrations of neuroactive steroids in depressed patients.
    Schüle C; Baghai TC; di Michele F; Eser D; Pasini A; Schwarz M; Rupprecht R; Romeo E
    Psychoneuroendocrinology; 2007 Jul; 32(6):669-80. PubMed ID: 17560730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Panic induction with cholecystokinin-tetrapeptide (CCK-4) Increases plasma concentrations of the neuroactive steroid 3alpha, 5alpha tetrahydrodeoxycorticosterone (3alpha, 5alpha-THDOC) in healthy volunteers.
    Eser D; di Michele F; Zwanzger P; Pasini A; Baghai TC; Schüle C; Rupprecht R; Romeo E
    Neuropsychopharmacology; 2005 Jan; 30(1):192-5. PubMed ID: 15467707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortisol metabolism in depressed patients and healthy controls.
    Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
    Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study.
    Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R
    World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
    Schüle C; Baghai T; Zwanzger P; Ella R; Eser D; Padberg F; Möller HJ; Rupprecht R
    Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine inhibits salivary cortisol concentrations in anorexia nervosa.
    Schüle C; Sighart C; Hennig J; Laakmann G
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1015-9. PubMed ID: 16644086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine.
    Serra M; Pisul MG; Dazzi L; Purdy RH; Biggio G
    J Psychopharmacol; 2002 Jun; 16(2):133-8. PubMed ID: 12095071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients.
    Peña S; Baccichet E; Urbina M; Carreira I; Lima L
    Int Immunopharmacol; 2005 Jun; 5(6):1069-76. PubMed ID: 15829422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.
    Scharnholz B; Weber-Hamann B; Lederbogen F; Schilling C; Gilles M; Onken V; Frankhauser P; Kopf D; Deuschle M
    Psychiatry Res; 2010 May; 177(1-2):109-13. PubMed ID: 20381159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in CCK-4 induced panic after treatment with the GABA-reuptake inhibitor tiagabine are associated with an increase in 3alpha,5alpha-tetrahydrodeoxycorticosterone concentrations.
    Zwanzger P; Eser D; Romeo E; di Michele F; Baghai TC; Pasini A; Padberg F; Rupprecht R
    Psychoneuroendocrinology; 2009 Nov; 34(10):1586-9. PubMed ID: 19501468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between mirtazapine dose, plasma concentration, response, and side effects in clinical practice.
    Grasmäder K; Verwohlt PL; Kühn KU; Frahnert C; Hiemke C; Dragicevic A; von Widdern O; Zobel A; Maier W; Rao ML
    Pharmacopsychiatry; 2005 May; 38(3):113-7. PubMed ID: 15902580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder.
    Hardoy MC; Serra M; Carta MG; Contu P; Pisu MG; Biggio G
    J Clin Psychopharmacol; 2006 Aug; 26(4):379-84. PubMed ID: 16855455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial agonism by 3alpha,21-dihydroxy-5beta-pregnan-20-one at the gamma-aminobutyric acidA receptor neurosteroid site.
    Xue BG; Whittemore ER; Park CH; Woodward RM; Lan NC; Gee KW
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1095-101. PubMed ID: 9190841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirtazapine for treatment-resistant depression: a preliminary report.
    Wan DD; Kundhur D; Solomons K; Yatham LN; Lam RW
    J Psychiatry Neurosci; 2003 Jan; 28(1):55-9. PubMed ID: 12587851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.